Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2003
09/25/2003US20030180301 Prevention organ rejection; induction immunology response; reduce fibrosis
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180293 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
09/25/2003US20030180288 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
09/25/2003CA2488928A1 Method of modulating inflammatory response
09/25/2003CA2479350A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
09/25/2003CA2479141A1 Pyridone derivatives
09/25/2003CA2478997A1 Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/25/2003CA2478211A1 Nk1 antagonists
09/25/2003CA2477832A1 Methods of treating diabetes using pde 11a inhibitors
09/25/2003CA2476746A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/24/2003EP1346993A1 Lactam compounds and medicinal use thereof
09/24/2003EP1346053A2 Polynucleotides encoding human phosphatases
09/24/2003EP1346051A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345938A1 Tricyclic crf receptor antagonists
09/24/2003EP1345937A1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/24/2003EP1345935A2 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/24/2003EP1345933A2 Process for making substituted 8-arylquinolinium benzenesulfonate
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345909A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1345609A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
09/24/2003EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/24/2003EP1345600A1 New clinical treatment
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists
09/24/2003EP1080055B1 24-hydroxyvitamin d, analogs and uses thereof
09/24/2003EP1054868B1 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003EP1043308B1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
09/24/2003EP1021444B1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1444589A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
09/24/2003CN1444587A Dihydropyridine soft drug and related to composition and method
09/24/2003CN1444570A Non-steroidal inflammation inhibitors
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444563A Quinoline and quinazoline derivatives
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/24/2003CN1122032C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624176 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624157 Antitumor agents
09/23/2003CA2062973C Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076435A1 Pyrimidine compounds
09/18/2003WO2003076434A1 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
09/18/2003WO2003076433A1 Pyrimidine compounds
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003075931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075911A1 Use of ppar alpha agonists for the treatment of vascular and renal diseases
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003059296A3 Compositions comprising collagen and metalloprotease inhibitors
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003028600B1 Wipe formulation
09/18/2003WO2002083700B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176417 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
09/18/2003US20030176413 Polycyclic guanine derivative phosphodiesterase V inhibitors
09/18/2003US20030176405 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176340 For therapy of renal failure
09/18/2003US20030176339 For therapy and prophylaxis of diabetes, obesity, arteriosclerosis, hyperlipemia, hypertriglyceridemia, hypo-high density lipoproteinemia, hypoapolipoproteinemia A-I or nervous disorders
1 ... 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 ... 562